DC
Defilade Capital Management, L.P.
13F filer · CIK 0002088557Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$747MU.S. long equity reported on 13F
Positions3919 new · 11 closed
Net flow last quarter-$20.3MBuys minus sells
Top 10 positions weight46.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202639 positions | |||||
| $46.9M | 6.28% | 0.00% | +88.9% | Q4 2025 | |
| $42.7M | 5.71% | 0.03% | +21.0% | Q4 2025 | |
| $42M | 5.62% | 0.15% | New | Q2 2026 | |
| $39M | 5.22% | 0.35% | New | Q2 2026 | |
| $35.4M | 4.74% | 0.52% | +15.3% | Q1 2026 | |
| $31.1M | 4.17% | 0.28% | New | Q2 2026 | |
| $30M | 4.02% | 0.13% | +44.6% | Q4 2025 | |
| $27.3M | 3.66% | 0.16% | -45.2% | Q1 2026 | |
| $26.9M | 3.61% | 0.26% | New | Q2 2026 | |
| $26M | 3.49% | 0.01% | New | Q2 2026 | |
| $25.9M | 3.47% | 0.02% | New | Q2 2026 | |
| $25.3M | 3.39% | 0.15% | +82.8% | Q4 2025 | |
| $24.4M | 3.27% | 0.19% | New | Q2 2026 | |
| $23.7M | 3.18% | 0.02% | New | Q2 2026 | |
| $21.3M | 2.85% | 0.17% | -7.2% | Q4 2025 | |
| $20.3M | 2.72% | 0.92% | New | Q2 2026 | |
| $19.1M | 2.56% | 0.45% | New | Q2 2026 | |
| $15.5M | 2.08% | 0.04% | -73.8% | Q4 2025 | |
| $15.5M | 2.07% | 0.42% | -58.4% | Q4 2025 | |
| $15.2M | 2.04% | 0.23% | +11.6% | Q4 2025 | |
| $14.7M | 1.97% | 0.20% | -46.8% | Q1 2026 | |
| $14.6M | 1.96% | 0.68% | +0.2% | Q4 2025 | |
| $13.9M | 1.86% | 4.36% | -1.1% | Q4 2025 | |
| $12M | 1.61% | 0.63% | New | Q2 2026 | |
| $11.6M | 1.55% | 1.06% | -38.5% | Q4 2025 | |
| $11.3M | 1.52% | 1.01% | +24.3% | Q1 2026 | |
| $11.2M | 1.50% | 3.53% | New | Q2 2026 | |
| $11M | 1.48% | 0.10% | -60.6% | Q4 2025 | |
| $11M | 1.47% | 0.92% | New | Q2 2026 | |
| $10.5M | 1.41% | 2.19% | +16.9% | Q4 2025 | |
| $10.2M | 1.36% | 0.18% | Not reported | Q4 2025 | |
| $10.1M | 1.35% | 0.25% | -71.2% | Q4 2025 | |
| $9.3M | 1.24% | 0.11% | Not reported | Q4 2025 | |
| $9.24M | 1.24% | 0.65% | New | Q2 2026 | |
| $9.2M | 1.23% | 0.14% | -64.3% | Q4 2025 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $8.96M | 1.20% | 0.23% | New | Q2 2026 |
| $8.83M | 1.18% | 0.20% | Not reported | Q4 2025 | |
| $3.1M | 0.41% | 2.92% | New | Q2 2026 | |
| $2.4M | 0.32% | 0.95% | Not reported | Q1 2026 | |
| Q1 2026Reported Jun 12, 202631 positions | |||||
| $52.4M | 7.35% | 0.30% | New | Q1 2026 | |
| $46M | 6.46% | 0.55% | +94.8% | Q4 2025 | |
| $43.9M | 6.16% | 0.10% | +243.8% | Q4 2025 | |
| $41.1M | 5.77% | 0.03% | -33.6% | Q4 2025 | |
| $33.8M | 4.75% | 0.14% | +120.0% | Q4 2025 | |
| $32.8M | 4.61% | 1.02% | -25.4% | Q4 2025 | |
| $31.9M | 4.48% | 0.09% | +289.8% | Q4 2025 | |
| $31.2M | 4.38% | 0.02% | +48.2% | Q4 2025 | |
| $30.7M | 4.31% | 0.16% | -13.1% | Q4 2025 | |
| $30.5M | 4.29% | 0.26% | +32.6% | Q4 2025 | |
| $27.7M | 3.88% | 0.21% | New | Q1 2026 | |
| $26.1M | 3.67% | 0.86% | +107.1% | Q4 2025 | |
| $25.6M | 3.60% | 0.45% | New | Q1 2026 | |
| $22.4M | 3.15% | 1.72% | +21.9% | Q4 2025 | |
| $22.3M | 3.13% | 0.19% | +132.0% | Q4 2025 | |
| $19.4M | 2.72% | 0.38% | -47.3% | Q4 2025 | |
| $19M | 2.67% | 0.00% | -35.2% | Q4 2025 | |
| $18.9M | 2.66% | 0.38% | New | Q1 2026 | |
| $18.7M | 2.63% | 0.62% | New | Q1 2026 | |
| $17.7M | 2.48% | 0.07% | -40.6% | Q4 2025 | |
| $15.6M | 2.19% | 1.88% | +215.0% | Q4 2025 | |
| $14.6M | 2.05% | 1.11% | New | Q1 2026 | |
| $13.6M | 1.91% | 0.21% | -38.0% | Q4 2025 | |
| NNUVLNuvalent, Inc. | $13.3M | 1.87% | 4.15% | -51.7% | Q4 2025 |
| $12.6M | 1.77% | 0.68% | +118.2% | Q4 2025 | |
| $11.9M | 1.67% | 0.08% | -39.4% | Q4 2025 | |
| $11.5M | 1.62% | 0.09% | -47.4% | Q4 2025 | |
| $11M | 1.54% | 4.70% | +8.3% | Q4 2025 | |
| $10.7M | 1.50% | 0.81% | New | Q1 2026 | |
| $2.67M | 0.38% | 0.21% | New | Q1 2026 | |
| $2.49M | 0.35% | 0.95% | New | Q1 2026 | |
| Q4 2025Reported Feb 13, 202633 positions | |||||
| $54.9M | 7.44% | 0.04% | New | Q4 2025 | |
| $52M | 7.05% | 0.01% | New | Q4 2025 | |
| $50M | 6.78% | 0.02% | New | Q4 2025 | |
| $48.6M | 6.59% | 1.38% | New | Q4 2025 | |
| $44M | 5.96% | 0.73% | New | Q4 2025 | |
| $34.3M | 4.65% | 0.00% | New | Q4 2025 | |
| $34.3M | 4.65% | 0.14% | New | Q4 2025 | |
| $30.9M | 4.18% | 1.52% | New | Q4 2025 | |
| $28.9M | 3.92% | 0.18% | New | Q4 2025 | |
| $28.5M | 3.86% | 0.11% | New | Q4 2025 | |
| NNUVLNuvalent, Inc. | $27.1M | 3.67% | 8.60% | New | Q4 2025 |
| $25.9M | 3.51% | 0.01% | New | Q4 2025 | |
| $24.2M | 3.28% | 0.28% | New | Q4 2025 | |
| $23.3M | 3.16% | 0.20% | New | Q4 2025 | |
| $21.7M | 2.94% | 1.97% | New | Q4 2025 | |
| $20.2M | 2.74% | 0.35% | New | Q4 2025 | |
| $20M | 2.71% | 0.18% | New | Q4 2025 | |
| $18.3M | 2.48% | 0.14% | New | Q4 2025 | |
| $16.3M | 2.20% | 0.06% | New | Q4 2025 | |
| $15.8M | 2.14% | 0.03% | New | Q4 2025 | |
| $15.7M | 2.13% | 0.80% | New | Q4 2025 | |
| $14.9M | 2.01% | 0.44% | New | Q4 2025 | |
| $13.2M | 1.79% | 0.42% | New | Q4 2025 | |
| $10.8M | 1.47% | 0.42% | New | Q4 2025 | |
| $10.4M | 1.40% | 0.16% | New | Q4 2025 | |
| $9.51M | 1.29% | 2.21% | New | Q4 2025 | |
| $9.08M | 1.23% | 0.08% | New | Q4 2025 | |
| $8.7M | 1.18% | 0.02% | New | Q4 2025 | |
| $8.28M | 1.12% | 0.32% | New | Q4 2025 | |
| $5.23M | 0.71% | 0.10% | New | Q4 2025 | |
| $4.97M | 0.67% | 4.36% | New | Q4 2025 | |
| $4.23M | 0.57% | 0.34% | New | Q4 2025 | |
| $3.69M | 0.50% | 0.68% | New | Q4 2025 | |
Premium opens every quarter this fund has filed